3-Ethynylbenzenesulfonyl chloride | 1314900-33-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-Ethynylbenzenesulfonyl chloride
• CAS: 1314900-33-8
• 化学式: C₈H₅ClO₂S
• mdl: MFCD19201299
• 分子量: 200.645
• InChiKey: MOYPCQHELPVQTB-UHFFFAOYSA-N

物化性质

• 沸点：
  307.4±25.0 °C(Predicted)
• 密度：
  1.44±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  42.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  哌啶 、 3-Ethynylbenzenesulfonyl chloride 以 二氯甲烷 为溶剂， 反应 0.33h， 生成 1-(3-ethynylbenzenesulfonyl)-piperidine
  参考文献：
  名称：

  Preparation of arylsulfonyl chlorides by chlorosulfonylation of in situ generated diazonium salts using a continuous flow reactor

  摘要：

  描述了一种从苯胺起始材料制备芳基磺酰氯的新流程。反应条件温和，无需添加酸，并且适合连续流处理，比相应的批量方法更安全、易于规模化且劳动强度更低。

  DOI：

  10.1039/c0ob00450b
• 作为产物：
  描述：

  3-氨基苯乙炔 在 亚硝酸特丁酯 、 二氧化硫 、 苄基三乙基氯化铵 、 乙二醇 、 copper dichloride 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 生成 3-Ethynylbenzenesulfonyl chloride
  参考文献：
  名称：

  Preparation of arylsulfonyl chlorides by chlorosulfonylation of in situ generated diazonium salts using a continuous flow reactor

  摘要：

  描述了一种从苯胺起始材料制备芳基磺酰氯的新流程。反应条件温和，无需添加酸，并且适合连续流处理，比相应的批量方法更安全、易于规模化且劳动强度更低。

  DOI：

  10.1039/c0ob00450b

文献信息

• [EN] PYRIDINE COMPOUNDS AS SODIUM CHANNEL BLOCKERS<br/>[FR] COMPOSÉS PYRIDINES COMME BLOQUEURS DES CANAUX SODIQUES
  申请人：PURDUE PHARMA LP

  公开号：WO2012007836A1

  公开（公告）日：2012-01-19

  The invention relates to substituted pyridine compounds of Formula I: (I) or a pharmaceutically acceptable salt, prodrug, or solvate thereof, wherein A1, X, A2, R1a, R1b, R1c, G, and z are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula I to treat a disorder responsive to the blockade of sodium channels. Compounds of the present invention are especially useful for treating pain.

  该发明涉及公式I的取代吡啶化合物：(I)或其药学上可接受的盐、前药或溶剂化合物，其中A1、X、A2、R1a、R1b、R1c、G和z的定义如规范中所述。该发明还涉及利用公式I的化合物治疗对钠通道阻滞有响应的疾病。本发明的化合物特别适用于治疗疼痛。
• [EN] CD16A BINDING AGENTS AND USES THEREOF<br/>[FR] AGENTS DE LIAISON À CD16A ET LEURS UTILISATIONS
  申请人：KLEO PHARMACEUTICALS INC

  公开号：WO2019136442A1

  公开（公告）日：2019-07-11

  Among other things, the present disclosure provides compounds, compositions thereof, and methods of using the same. In some embodiments, compounds of the present disclosure bind to Fc receptors, e.g., CD16a. In some embodiments, compounds of the present disclosure are useful for treating various conditions, disorders or diseases including cancer.

  在其他方面，本公开提供了化合物、其组合物以及使用这些化合物的方法。在一些实施例中，本公开的化合物与Fc受体结合，例如CD16a。在一些实施例中，本公开的化合物可用于治疗包括癌症在内的各种疾病、疾病或疾病。
• 1H-Pyrazolo[3,4-g]hexahydro-isoquinolines as potent GR antagonists with reduced hERG inhibition and an improved pharmacokinetic profile
  作者：Hazel J. Hunt、Joseph K. Belanoff、Emily Golding、Benoit Gourdet、Timothy Phillips、Denise Swift、Jennifer Thomas、John F. Unitt、Iain Walters

  DOI：10.1016/j.bmcl.2015.10.097

  日期：2015.12

  We report the further optimization of our series 1H-pyrazolo[3,4-g]hexahydro-isoquinoline sulfonamides as GR antagonists. By incorporating a heteroaryl ketone group at the ring junction, we have obtained compounds with excellent functional GR antagonism. Optimization of the sulfonamide substituent has provided compounds with a very desirable overall profile, including minimal hERG activity, good bioavailability and in vivo efficacy. (C) 2015 Elsevier Ltd. All rights reserved.
• RAPAMYCIN ANALOGS AS MTOR INHIBITORS
  申请人：Revolution Medicines, Inc.

  公开号：US20210094975A1

  公开（公告）日：2021-04-01

  The present disclosure relates to mTOR inhibitors. Specifically, the embodiments are directed to compounds and compositions inhibiting mTOR, methods of treating diseases mediated by mTOR, and methods of synthesizing these compounds.
• Preparation of arylsulfonyl chlorides by chlorosulfonylation of in situ generated diazonium salts using a continuous flow reactor
  作者：Laia Malet-Sanz、Julia Madrzak、Steven V. Ley、Ian R. Baxendale

  DOI：10.1039/c0ob00450b

  日期：——

  A new flow procedure for the preparation of arylsulfonyl chlorides from aniline starting materials is described. The reaction conditions are mild, requiring no added acid and are amenable to continuous flow processing, in a safe, easily scalable and less labour intensive way than the corresponding batch method.

  描述了一种从苯胺起始材料制备芳基磺酰氯的新流程。反应条件温和，无需添加酸，并且适合连续流处理，比相应的批量方法更安全、易于规模化且劳动强度更低。